Peptide-based therapeutics
Gubra's Biotech unit develops a growing pipeline of peptide-based therapeutics targeting metabolic diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Gubra is a biotech company with Biotech, CRO Services, and Ventures business units.
Founded in 2008, Gubra has grown from a metabolic research specialist into a diversified organization of more than 300 scientists and experts. Gubra advances proprietary therapeutic programs, provides preclinical research services to global partners, and creates drug discovery opportunities through venture structures.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Gubra delivers preclinical research services to global partners.
Gubra's Biotech unit develops a growing pipeline of peptide-based therapeutics targeting metabolic diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Gubra's preclinical CRO provides capabilities in in vivo pharmacology, ex vivo assays, peptide chemistry, molecular pharmacology, histology, stereology, AI-enhanced imaging, and bioinformatics.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 5, 2026, September 6, 2026, September 15, 2026, September 18, 2026, September 19, 2026, September 21, 2026, September 27, 2026, October 7, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.